Pharmafile Logo
Pharmafocus logo
Advanced Search
ipos0_l

Sanofi will pay Regeneron $582m in deal restructuring

January 7, 2019
Sales and Marketing Deals, Regeneron, Sanofi, biotech, pharma

French pharmaceutical giant Sanofi will pay US biotech Regeneron $582 million, as part of a restructuring of an earlier deal …

News
stocks1

Aevi Genomic Medicine’s share price crashes 75% following ADHD trial failure

January 4, 2019
Medical Communications, Research and Development ADHD, AEVI-001, Aevi Genomic Medicine, clinical trial failure, pharma

Aevi Genomic Medicine, a US drugmaker based outside of Philadelphia, has seen its share value plummet by 75% following the …

News
astrazeneca_sign_sky

NICE recommends AstraZeneca’s Fasenra as third treatment option for severe asthma

January 4, 2019
Medical Communications, Sales and Marketing AstraZeneca, Fasenra, NHS, NICE, UK, asthma, pharma

It’s good news for both asthma patients and AstraZeneca after UK drug watchdog NICE saw fit to recommend the drugmaker’s …

News
img_4190-e1376666350337-web

MHRA issues recall of irbesartan blood pressure meds over carcinogen contamination concerns

January 4, 2019
Manufacturing and Production, Medical Communications MHRA, irbesartan, pharma, sartan, valsartan

Following a number of recalls issued in the US and Europe in the latter half of 2018 for the blood …

News
takeda_usa_pharmaceuticals_u

Takeda unveils three new discovery and development collaborations in immuno-oncology

January 4, 2019
Medical Communications, Research and Development CAR-T, Crescendo Biologics, Memorial Sloan Kettering Cancer Center, Noile-Immune, Takeda, pharma

Takeda has revealed that it is set to bolster its novel immuno-oncology portfolio with three new research collaborations. The Japanese …

News
shutterstock_273326141

BMS to acquire Celgene for $74 billion in biggest-ever pharma deal

January 4, 2019
Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, acquisition, pharma

Starting off 2019 with a bang, Bristol-Myers Squibb has announced its intention to acquire fellow drugmaker Celgene as part of …

News

Children should be given flu vaccine to protect older people

December 21, 2018
Medical Communications epidemiology, flu, health, public health, vaccines

Parents are being urged to give their children the flu vaccine in order to protect ‘older people’ from the potentially …

News
gilead-sciences

Gilead inks $1.8 bn deal with immuno-oncology biotech Agenus

December 21, 2018
Medical Communications Agenus, Gilead, Lexington, Massachusetts, USA, immuno-oncology, oncology

California-based firm Gilead Sciences and Massachusetts-based immuno-oncology biotech Agenus have announced that they have entered into a partnership focused on …

News
38707779504_4778627b30_z

Top Ten most popular articles on Pharmafile.com of 2018!

December 21, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Business, biosimilars, brexit, pharma, top 10

Brexit, business and biosimilars, seemed to be the three themes of 2018. As Brexit negotiations reached a stalemate the pharmaceutical …

News
jj

J&J’s Baby powder tested in India and Bangladesh

December 21, 2018
Medical Communications Bangladesh, Cancer, India, J&J, JJ, asbestos

Bangladeshi authorities will collect and test samples of Johnson & Johnson’s baby powders for traces of cancer causing asbestos, after …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

December 21, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Eisai, Eli Lilly, Novartis, Teva, Tilray, brexit, celltrion, pharma, top 10

Deals dominated this week as GSK and Pfizer announced that they would combine their consumer healthcare units in a collaboration …

News

Merck KGaA hands over CAR-T therapy business to Intrexon in deal worth $175 million

December 20, 2018
Business Services, Medical Communications, Sales and Marketing CAR T, CAR-T, Cancer, Germany, Intrexon, Merck KGaA, darmstadt, oncology

German pharma firm Merck KGaA has agreed to hand over its CAR-T therapy business to US company Intrexon in a …

News
liz_barrett

Novartis Oncology CEO steps down after 11 months

December 20, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Liz Barret, the CEO of Swiss firm Novartis Oncology has said that she is standing down after being in the …

Appointment
800px-t_lymphocyte_16760076824

KCL researchers find link between overactive immune system and Chronic Fatigue Syndrome/ ME

December 20, 2018
Research and Development CFS, KCL, King's College London, Kings College London, ME

Chronic fatigue syndrome (CFS) or Myalgic encephalomyelitis (ME) may be caused by an overactive immune system, according to researchers at …

News
306782624_cec6c1a70c_z

Medics in Vanuatu transport vaccines via drone

December 20, 2018
Business Services, Medical Communications Transport, Vanuata, drone, supply chain, vaccines

Medics in the remote archipelago of Vanuatu have begun to deliver vaccines using a commercial drone. The logistical success marks …

News
8643990124_7c11fee008_z

Gilead and Scholar Rock collaborate on fibrosis in deal worth more than $80m

December 20, 2018
Business Services, Research and Development Califonia, Gilead, Scholar Rock, USA, fibrosis

California-based antiviral drugs specialist Gilead Sciences has entered into a strategic partnership with Cambridge, Massachusetts-based biotech Scholar Rock as part …

News
astrazeneca_plaque

AstraZeneca scores hat trick in ovarian cancer and anaemia clinical trials

December 20, 2018
Research and Development AstraZeneca, anaemia, oncology, ovarian cancer, pharma

Anglo-Swedish multinational AstraZeneca has revealed that its ovarian cancer drug (Lynparza) and anaemia treatment (Roxadustat) have met their goals in …

News
bmssyracuseny

Taisho Pharma to buy Bristol-Myers Squibb’s consumer health business in deal worth $1.6 bn

December 19, 2018
Business Services BMS, Japan, M&A, MA, Taisho, deal

Japanese company Taisho Pharmaceuticals has offered Bristol-Myers Squibb $1.6 billion for its UPSA consumer health business. With more than a …

News

NICE recommends Lenvima as alternative first-line therapy for advanced liver cancer

December 19, 2018
Research and Development, Sales and Marketing Lenvima, NICE, UK, liver cancer, pharma

UK drug watchdog NICE has revealed that it has recommended Eisai’s Lenvima (lenvatinib) for use on the NHS in England …

News
astrazeneca-sign

China becomes first country to approve roxadustat in chronic kidney disease

December 19, 2018
Research and Development, Sales and Marketing AstraZeneca, China, chronic kidney disease, pharma

AstraZeneca has announced that its partner Fibrogen has secured the first national approval for its hypoxia-inducible factor prolyl hydroxylase inhibitor …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026